CClinicalTrials.gg
RecruitingNCT07375680Updated Apr 8, 2026

HbA1c Levels and Gastric Emptying Assessed by Gastric Ultrasound

An observational study in Delayed Gastric Emptying, Diabetes Mellitus and Pulmonary Aspiration, sponsored by Kutahya Health Sciences University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-04-08.

Sponsored by Kutahya Health Sciences University · Observational

From the registry’s dates

  • Started Feb 2026; still recruiting 7 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
134
Ages
18 Years to 70 Years
Sex
All
01

Study summary

Delayed gastric emptying increases the risk of pulmonary aspiration during general anesthesia. Diabetes mellitus and poor long-term glycemic control have been associated with impaired gastric motility. Hemoglobin A1c (HbA1c) is a marker of long-term glycemic control; however, its relationship with gastric emptying in surgical patients is not fully understood.

This prospective observational study aims to evaluate the association between HbA1c levels and gastric emptying using preoperative bedside gastric ultrasonography. Adult patients scheduled for elective surgery under general anesthesia will undergo gastric ultrasound examination after standard fasting. Gastric antral cross-sectional area and estimated gastric volume will be assessed and compared according to HbA1c levels.

The findings of this study may help improve preoperative risk stratification for aspiration and support individualized anesthetic management in patients with impaired glycemic control.

Read the detailed description

This prospective observational study is designed to evaluate the relationship between hemoglobin A1c (HbA1c) levels and gastric emptying in adult surgical patients using bedside gastric ultrasonography.

Adult patients aged 18 to 70 years, scheduled for elective surgery under general anesthesia, will be enrolled. After standard preoperative fasting according to current guidelines, all participants will undergo a preoperative gastric ultrasound examination performed by a trained anesthesiologist. The gastric antrum will be assessed in standardized positions, and the antral cross-sectional area will be measured. Estimated gastric volume will be calculated using validated ultrasound-based formulas.

HbA1c levels will be obtained from preoperative laboratory records, and patients will be analyzed according to their HbA1c values. Gastric ultrasound findings, including antral cross-sectional area and estimated gastric volume, will be compared across different HbA1c levels.

Demographic data, anthropometric measurements including body mass index and waist circumference, fasting duration, and relevant clinical characteristics will also be recorded. The primary objective is to assess the association between HbA1c levels and gastric emptying parameters. Secondary analyses will explore potential factors associated with delayed gastric emptying.

The results of this study may contribute to improved preoperative risk assessment for pulmonary aspiration and support individualized anesthetic management in patients with impaired glycemic control.

02

Conditions studied

  • Delayed Gastric Emptying
  • Diabetes Mellitus
  • Pulmonary Aspiration

Keywords

  • Hemoglobin A1c
  • Gastric Ultrasonography
  • General Anesthesia
  • Preoperative Assessment
03

In context

Gastroparesis

307 studies on the registry are indexed under Gastroparesis; 68 are open to participants now.

This study's planned enrollment of 134 is above the median of 100 across 77 observational studies indexed under Gastroparesis.

Browse Gastroparesis studies →

Lead sponsor

Kutahya Health Sciences University is the lead sponsor of 209 studies on the registry; 46 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients aged 18 to 70 years scheduled for elective surgery under general anesthesia at a tertiary care hospital.

Inclusion criteria

Adults aged 18 to 70 years. ASA physical status I-III. Scheduled for elective surgery under general anesthesia. Ability to provide written informed consent.

Exclusion criteria

Exclusion Criteria:

Scheduled for emergency surgery. Refusal or inability to provide informed consent. Pregnancy. Age \<18 years or >70 years. History of gastric surgery. Neuromuscular disease. Current use of opioid or anticholinergic medications.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
134 participants (estimated)
Patient registry
No

Groups and cohorts

  • Study Population

    Adult patients scheduled for elective surgery under general anesthesia who undergo preoperative bedside gastric ultrasonography as part of an observational study.

06

What researchers measure

Primary outcomes

  1. Gastric emptying assessed by gastric ultrasound

    Gastric emptying will be assessed preoperatively using bedside gastric ultrasonography by measuring gastric antrum cross-sectional area and estimating gastric volume with validated ultrasound-based methods.

    Time frame: The preoperative period,immediately before induction of anesthesia

07

Study locations

1 of 1 sites recruiting
  • Kutahya Health Science University Training and Research Hospital
    Kütahya, Kütahya, Turkey (Türkiye)
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07375680
Lead sponsor
Kutahya Health Sciences University
Responsible party
Merve Yaman (MD,Assistant Professor of Anesthesiology, Kutahya Health Sciences University) — Principal investigator
First posted
Jan 29, 2026
Start date
Feb 15, 2026
Primary completion
Aug 15, 2026 (estimated)
Completion
Sep 2026 (estimated)
Last update
Apr 8, 2026

Study contacts

merve yaman, MD, Assistant Professor
Contact
merve.yaman@ksbu.edu.tr
+905363794742
emine gök, MD
Contact
emine.gok@ksbu.gov.tr
+905050270167
merve yaman, MD, Assistant Professor
principal investigator · Kutahya Health Science University
emine gök, MD
study director · Kutahya Health Science University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion